ERs nearly doubled facility fees as visits decreased

Facility fees are charged for nearly every visit to an emergency room (ER), with departments arguing they’re necessary to keep their doors open. Between 2009 and 2015, ERs across the country increasingly used higher intensity codes for ER visits, leading to an 89 percent increase in facility fees.

The analysis from the Health Care Cost Institute (HCCI) and Vox—part of an investigation into hospital prices which has led to warnings from the American Hospital Association (AHA)—covered 70 million insurance bills for ER visits and focused on what health plans paid facilities for these fees, rather than the hospitals’ list price.

Overall, spending on ER fees rose from $4.3 billion to $7.3 billion between 2009 and 2015, even though the number of ER visits declined from 10.5 million to 9.4 million over the same time frame.

“If you have a monopoly—and when it comes to the ER, it’s a monopoly—you can set any price you want,” said Robert Derlet, MD, a professor emeritus in emergency medicine at the University of California Davis. “What is going to deter me from increasing my price? Who can stop me? If I’m the financial officer for the hospital, I might even get a bonus for doing this.”

The AHA justified the increases by claiming ER visits are actually on the rise and the patients being treated represent more complex cases.

Read more at the link below:

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation. 

Trimed Popup
Trimed Popup